Abstract
The colorectal carcinoma-associated protein GA733-2 is one of the representative candidate protein for the development of plant-derived colorectal cancer vaccine. Despite of its significant importance for colorectal vaccine development, low efficiency of GA733-2 production limits its wide applications. To improve productivity of GA733-2 in plants, we here tested multiple factors that affect expression of recombinant GA733-2 (rGA733-2) and rGA733 fused to fragment crystallizable (Fc) domain (rGA733-Fc) protein. The rGA733-2 and rGA733-Fc proteins were highly expressed when the pBINPLUS vector system was used for transient expression in tobacco plants. In addition, the length of interval between rGA733-2 and left border of T-DNA affected the expression of rGA733 protein. Transient expression analysis using various combinations of Agrobacterium tumefaciens strains (C58C1, LBA4404, and GV3101) and tobacco species (Nicotiana tabacum cv. Xanthi nc and Nicotiana benthamiana) revealed that higher accumulation of rGA733-2 and rGA733-Fc proteins were obtained by combination of A. tumefaciens LBA4404 and Nicotiana benthamiana. Transgenic plants generated by introduction of the rGA733-2 and rGA733-Fc expression cassettes also significantly accumulated corresponding recombinant proteins. Bioactivity and stability of the plant-derived rGA733 and rGA733-Fc were evaluated by further in vitro assay, western blot and N-glycosylation analysis. Collectively, we here suggest the optimal condition for efficient production of functional rGA733-2 protein in tobacco system.






Similar content being viewed by others
References
Abakushina EV, Gelm YV, Pasova IA, Bazhin AV (2019) Immunotherapeutic approaches for the treatment of colorectal cancer. Biochemistry (Mosc) 84:720–728
Armstrong A, Eck SL (2003) EpCAM: A new therapeutic target for an old cancer antigen. Cancer Biol Ther 2:320–326
Ashkenazi A, Chamow SM (1997) Immunoadhesins as research tools and therapeutic agents. Curr Opin Immunol 9:195–200
Bakker H, Bardor M, Molthoff JW, Gomord V, Elbers I, Stevens LH, Jordi W, Lommen A, Faye L, Lerouge P, Bosch D (2001) Galactose-extended glycans of antibodies produced by transgenic plants. Proc Natl Acad Sci U S A 98:2899–2904
Basak S, Speicher D, Wunner W, Maul G, Herlyn D, Eck S, Simmons MS (1998) Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue. J Natl Cancer Inst 90:691–697
Benchabane M, Goulet C, Rivard D, Faye L, Gomord V, Michaud D (2008) Preventing unintended proteolysis in plant protein biofactories. Plant Bioechnol J 6:633–648
Blokhina EA, Mardanova ES, Stepanova LA, Tsybalova LM, Ravin NV (2020) Plant-produced recombinant Influenza A virus candidate vaccine based on flagellin linked to conservative fragments of M2 protein and hemagglutintin. Plants 9:162
Bosch D, Schots A (2010) Plant glycans: friend or foe in vaccine development? Expert Rev Vaccines 9:835–842
Bracci L, Fragale A, Gabriele L, Moschella F (2020) Towards a systems immunology approach to unravel responses to cancer immunotherapy. Front Immunol 11:1
Bradley DW, Zaitlin M (1971) Replication of tobacco mosaic virus: II. The in vitro synthesis of high molecular weight virus-specific RNAs. Virol J 45:192–199
Brodzik R, Glogowska M, Bandurska K, Okulicz M, Deka D, Ko K, van der Linden J, Leusen JH, Pogrebnyak N, Golovkin M, Steplewski Z, Koprowski H (2006) Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells. Proc Natl Acad Sci USA 103:8804–8809
Brodzik R, Spitsin S, Golovkin M, Bandurska K, Portocarrero C, Okulicz M, Steplewski Z, Koprowski H (2008) Plant-derived EpCAM antigen induces protective anti-cancer response. Cancer Immunol Immunother 57:317–323
Carter PJ (2011) Introduction to current and future protein therapeutics: a protein engineering perspective. Exp Cell Res 317:1261–1269
Castilho A, Gattinger P, Grass J, Jez J, Pabst M, Altmann F, Gorfer M, Strasser R, Steinkellner H (2011) N-Glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Glycobiology 21:813–823
Czajkowsky DM, Hu J, Shao Z, Pleass RJ (2012) Fc-fusion proteins: new developments and future perspectives. EMBO Mol Med 4:1015–1028
Daniell H, Singh ND, Mason H, Streatfield SJ (2009) Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci 14:669–679
Daniell H, Streatfield SJ, Wycoff K (2001) Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci 6:219–226
De Buck S, Nolf J, De Meyer T, Virdi V, De Wilde K, Van Lerberge E, Van Droogenbroeck B, Depicker A (2013) Fusion of an Fc chain to a VHH boosts the accumulation levels in Arabidopsis seeds. Plant Biotechnol J 11:1006–1016
Fox J (2012) First plant-made biologic approved. Nat Biotechnol 30:472–472
Francis MJ (2018) Recent advances in vaccine technologies. Vet Clin North Am Small Anim Pract 48:231–241
Fu Y-Y, Zhao J, Park J-H, Choi G-W, Park K, Lee Y, Chung I (2018) Human colorectal cancer antigen GA733-2-Fc fused to endoplasmic reticulum retention motif KDEL enhances its immunotherapeutic effects. J Cancer Res Ther 14:748–757
Golovkin M, Spitsin S, Andrianov V, Smirnov Y, Xiao Y, Pogrebnyak N, Markley K, Brodzik R, Gleba Y, Isaacs SN, Koprowski H (2007) Smallpox subunit vaccine produced in planta confers protection in mice. Proc Natl Acad Sci USA 104:6864–6869
Grosse-Holz F, Kelly S, Blaskowski S, Kaschani F, Kaiser M, van der Hoorn RAL (2018) The transcriptome, extracellular proteome and active secretome of agroinfiltrated Nicotiana benthamiana uncover a large, diverse protease repertoire. Plant Biotechnol J 16:1068–1084
Hariharan V, Kane RS (2020) Glycosylation as a tool for rational vaccine design. Biotechnol Bioeng 117:2556–2570
Horsch RB, Fry J, Hoffmann N, Neidermeyer J, Rogers SG, Fraley RT (1989) Leaf disc transformation. In: Gelvin SB, Schilperoort RA, Verma DPS (eds) Plant Molecular Biology Manual. Springer, Dordrecht
Jakob F, Lehmann C, Martinez R, Schwaneberg U (2013) Increasing protein production by directed vector backbone evolution. AMB Express 3:39
Joung YH, Park SH, Moon K-B, Jeon J-H, Cho H-S, Kim H-S (2016) The last ten years of advancements in plant-derived recombinant vaccines against Hepatitis B. Int J Mol Sci 17:1715
Koido S (2013) Immunotherapy for colorectal cancer. World J Gastroenterol 19:8531
Lee JH, Ko K (2017) Production of recombinant anti-cancer vaccines in plants. Biomol Ther 25:345–353
Li W, Berencsi K, Basak S, Somasundaram R, Ricciardi RP, Gönczöl E, Zaloudik J, Linnenbach A, Maruyama H, Miniou P, Herlyn D (1997) Human colorectal cancer (CRC) antigen CO17-1A/GA733 encoded by adenovirus inhibits growth of established CRC cells in mice. J Immunol Res 159:763–769
Lim CY, Lee KJ, Oh DB, Ko K (2014) Effect of the developmental stage and tissue position on the expression and glycosylation of recombinant glycoprotein GA733-FcK in transgenic plants. Front Plant Sci 5:778
Lomonossoff GP, D’Aoust MA (2016) Plant-produced biopharmaceuticals: a case of technical developments driving clinical deployment. Science 353:1237–1240
Lu Z, Lee K-J, Shao Y, Lee J-H, So Y, Choo Y-K, Oh D-B, Hwang K-A, Oh SH, Ham YS, Ko K (2012) Expression of GA733-Fc fusion protein as a vaccine candidate for colorectal cancer in transgenic plants. BioMed Res Int 2012:364240
Mamaloudis I, Zacharoulis D, Samara M, Papadopoulos G, Samara S, Koukoulis G, Chatzitheofilou C, Kollia P (2015) Expression profile of the GA733 gene family in colorectal cancer: correlation with clinicopathological parameters. Genet Mol Res 14:14772–14781
Mardanova ES, Blokhina EA, Tsybalova LM, Peyret H, Lomonossoff GP, Ravin NV (2017) Efficient transient expression of recombinant proteins in plants by the novel pEff vector based on the genome of potato virus x. Front Plant Sci 8:1
Mason HS (2016) Recombinant immune complexes as versatile and potent vaccines. Hum Vaccin Immunother 12:988–989
Mason HS, Warzecha H, Mor T, Arntzen CJ (2002) Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol Med 8:324–329
McCormick AA (2011) Tobacco derived cancer vaccines for non-Hodgkin’s lymphoma: perspectives and progress. Hum Vaccin 7:305–312
McCormick AA, Reddy S, Reinl SJ, Cameron TI, Czerwinkski DK, Vojdani F, Hanley KM, Garger SJ, White EL, Novak J, Barrett J, Holtz RB, Tusé D, Levy R (2008) Plant-produced idiotype vaccines for the treatment of non-Hodgkin’s lymphoma: Safety and immunogenicity in a phase I clinical study. Proc Natl Acd Sci U S A 105:10131–10136
Nausch H, Mikschofsky H, Koslowski R, Meyer U, Broer I, Huckauf J (2012) High-Level Transient Expression of ER-Targeted Human Interleukin 6 in Nicotiana benthamiana. PLoS ONE 7:e48938
Obregon P, Chargelegue D, Drake PMW, Prada A, Nuttall J, Frigerio L, Ma JKC (2006) HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production. Plant Biotechnol J 4:195–207
Otten MA, van Egmond M (2004) The Fc receptor for IgA (FcalphaRI, CD89). Immunol Lett 92:23–31
Park SH, Kim A-Y, Ma SH, Kim HM, Kang HS, Maeng J-S, Ko K, Chung IS, Joung YH (2015a) Purification of human carcinoma antigen GA733-2 expressed in Escherichia coli and production of its polyclonal antibody in rabbit. Anim Cells Syst 19:188–193
Park SR, Lim CY, Kim DS, Ko K (2015b) Optimization of ammonium sulfate concentration for purification of colorectal cancer vaccine candidate recombinant protein GA733-FcK isolated from plants. Front Plant Sci 6:1040
Pinkhasov J, Alvarez ML, Rigano MM, Piensook K, Larios D, Pabst M, Grass J, Mukherjee P, Gendler SJ, Walmsley AM, Mason HS (2011) Recombinant plant-expressed tumour-associated MUC1 peptide is immunogenic and capable of breaking tolerance in MUC1.Tg mice. Plant Biotechnol J 9:991–1001
Prado GS, Bamogo PKA, de Abreu JAC, Gillet F-X, dos Santos VO, Silva MCM, Brizard J-P, Bemquerer MP, Bangratz M, Brugidou C, Sérémé D, Grossi-de-Sa MF, Lacombe S (2019) Nicotiana benthamiana is a suitable transient system for high-level expression of an active inhibitor of cotton boll weevil α-amylase. BMC Biotechnol 19:15
Rajaram S, Boikos C, Gelone DK, Gandhi A (2020) Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing. Ther Adv Vaccines Immunother 8:2515135520908121–2515135520908121
Rosales-Mendoza S, Angulo C, Meza B (2016) Food-grade organisms as vaccine biofactories and oral delivery vehicles. Trends Biotechnol 34:124–136
Rybicki EP (2009) Plant-produced vaccines: promise and reality. Drug Discov Today 14:16–24
Saejung W, Fujiyama K, Takasaki T, Ito M, Hori K, Malasit P, Watanabe Y, Kurane I, Seki T (2007) Production of dengue 2 envelope domain III in plant using TMV-based vector system. Vaccine 25:6646–6654
Sarvizadeh M, Ghasemi F, Tavakoli F, Sadat Khatami S, Razi E, Sharifi H, Biouki NM, Taghizadeh M (2019) Vaccines for colorectal cancer: an update. J Cell Biochem 120:8815–8828
Schillberg S, Raven N, Spiegel H, Rasche S, Buntru M (2019) Critical analysis of the commercial potential of plants for the production of recombinant proteins. Front Plant Sci 10:720–720
Schoberer J, Strasser R (2018) Plant glyco-biotechnology. Sem Cell Dev Biol 80:133–141
Schouten A, Roosien J, van Engelen FA, de Jong GA, Borst-Vrenssen AW, Zilverentant JF, Bosch D, Stiekema WJ, Gommers FJ, Schots A, Bakker J (1996) The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco. Plant Mol Biol 30:781–793
Shamloul M, Trusa J, Mett V & Yusibov V (2014) Optimization and Utilization of Agrobacterium-mediated Transient Protein Production in Nicotiana. JoVE:e51204.
Shanmugaraj B, Christine-Joy IB, Phoolcharoen W (2020) Plant molecular farming: a viable platform for recombinant biopharmaceutical production. Plants 9:1
Szala S, Froehlich M, Scollon M, Kasai Y, Steplewski Z, Koprowski H, Linnenbach AJ (1990) Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. Proc Natl Acad Sci USA 87:3542–3546
Takeyama N, Kiyono H, Yuki Y (2015) Plant-based vaccines for animals and humans: recent advances in technology and clinical trials. Ther Adv Vaccines 3:139–154
Tauriello DV, Calon A, Lonardo E, Batlle E (2017) Determinants of metastatic competency in colorectal cancer. Mol Oncol 11:97–119
Temraz S, Mukherji D, Shamseddine A (2014) Sequencing of treatment in metastatic colorectal cancer: where to fit the target. World J Gastroenterol 20:1993–2004
Tokmakov AA, Kurotani A, Takagi T, Toyama M, Shirouzu M, Fukami Y, Yokoyama S (2012) Multiple post-translational modifications affect heterologous protein synthesis. J Biol Chem 287:27106–27116
Tusé D, Nandi S, McDonald KA, Buyel JF (2020) The emergency response capacity of plant-based biopharmaceutical manufacturing-What it is and what it could be. Front Plant Sci 11:1
Ullrich KK, Hiss M, Rensing SA (2015) Means to optimize protein expression in transgenic plants. Curr Opin Biotechnol 32:61–67
Van Droogenbroeck B, Cao J, Stadlmann J, Altmann F, Colanesi S, Hillmer S, Robinson DG, Van Lerberge E, Terryn N, Van Montagu M, Liang M, Depicker A, Jaeger GD (2007) Aberrant localization and underglycosylation of highly accumulating single-chain Fv-Fc antibodies in transgenic Arabidopsis seeds. Proc Natl Acad Sci U S A 104:1430–1435
Verch T, Hooper DC, Kiyatkin A, Steplewski Z, Koprowski H (2004) Immunization with a plant-produced colorectal cancer antigen. Cancer Immunol Immunother 53:92–99
Wilson IB, Zeleny R, Kolarich D, Staudacher E, Stroop CJ, Kamerling JP, Altmann F (2001) Analysis of Asn-linked glycans from vegetable foodstuffs: widespread occurrence of Lewis a, core alpha1,3-linked fucose and xylose substitutions. Glycobiology 11:261–274
Wong-Arce A, González-Ortega O, Rosales-Mendoza S (2017) Plant-made vaccines in the fight against cancer. Trends Biotechnol 35:241–256
Zahin M, Joh J, Khanal S, Husk A, Mason H, Warzecha H, Ghim S-j, Miller DM, Matoba N, Jenson AB (2016) Scalable production of HPV16 L1 protein and VLPs from tobacco leaves. PLoS ONE 11:e0160995
Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE (2017) Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc Natl Acad Sci USA 114:12578–12583
Acknowledgements
This work was supported by a grant from the New breeding technologies development Program (Project No. PJ01487401), and the Next-Generation BioGreen21 Program (Project No. PJ01389401), Rural Development Administration, Republic of Korea.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Park, S.H., Ji, KY., Kim, H.M. et al. Optimization of the human colorectal carcinoma antigen GA733-2 production in tobacco plants. Plant Biotechnol Rep 15, 55–67 (2021). https://doi.org/10.1007/s11816-020-00657-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11816-020-00657-y


